SCHEMBL22587791

SCHEMBL22587791

O=C(Cc1ccc(C(F)(F)F)cc1)N1CCC2(CC1)C(=O)Nc1ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 2/20 0.47
▸ ME2 P23368 1/20 0.47
▸ ME1 P48163 1/20 0.47
▸ ME3 Q16798 1/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ CNR1 P21554 3/20 0.45
▸ OPRL1 P41146 2/20 0.45
▸ OPRM1 P35372 1/20 0.45
▸ OPRK1 P41145 1/20 0.45
▸ HTR1A P08908 3/20 0.43
▸ HTR2A P28223 3/20 0.43
▸ HTR7 P34969 3/20 0.43
▸ HTR6 P50406 3/20 0.43
▸ MEN1 O00255 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4953064 0.84 ENPP2 (0.52) MAPTTSHROPRL1OPRM1OPRK1
SCHEMBL31285887 0.83 PLD1 (0.46) HRH3ME2ME1ME3CYP3A4
SCHEMBL22605690 0.83 PLD1 (0.46) HRH3ME2ME1ME3CYP3A4
SCHEMBL1953465 0.83 RBP4 (0.52) CNR1OPRL1OPRM1OPRK1HTR1A
SCHEMBL22605695 0.82 TP53 (0.67) HRH3ME2ME1ME3CYP3A4
SCHEMBL30317058 0.82 TP53 (0.67) HRH3ME2ME1ME3CYP3A4
SCHEMBL13994637 0.78 PARP1 (0.43) MAPTSMN1; SMN2OPRL1OPRM1OPRK1
SCHEMBL4953825 0.78 PARP1 (0.43) MAPTSMN1; SMN2OPRL1OPRM1OPRK1
SCHEMBL4953381 0.78 ALDH1A1 (0.56) MAPTTSHRSMN1; SMN2MEN1KMT2A
SCHEMBL4954788 0.78 OPRM1 (0.53) OPRL1OPRM1OPRK1HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111848598-A Heterocyclic ring-containing compound, application thereof and composition containing heterocyclic ring-containing compound 健艾仕生物医药有限公司 2020-10-30 — — CN disclosed
WO-2020216378-A1 HETEROCYCLIC COMPOUND, APPLICATION THEREOF, AND COMPOSITION CONTAINING SAME 健艾仕生物医药有限公司 2020-10-29 — — WO disclosed
WO-2020216378-A1 HETEROCYCLIC COMPOUND, APPLICATION THEREOF, AND COMPOSITION CONTAINING SAME 健艾仕生物医药有限公司 2020-10-29 — — WO disclosed
Send feedback